Furthermore, Sareddy et al. (44) indicated that the activation of the unfolded protein response (UPR) pathway induced by KDM1A inhibitors reduced stem cells and induced differentiation and apoptosis in glioma stem cells. Here, KDM1A is linked to central nervous system cancer.